Serum Institute resumes COVID-19 vaccine exports
NEW DELHI: Serum Institute of India (SII) — the world’s largest vaccine maker — on Friday said it has resumed exports of Covishield vaccine to low- and middle-income countries with the first batch of consignment leaving its Pune facility.
The vaccine maker has cumulatively produced 1.25 billion doses so far, a company statement said.
“The first batches of its COVISHIELD COVID-19 vaccine left the SII manufacturing facility in Pune earlier today, for distribution to low- and middle-income countries via the COVAX mechanism,” it said.
“SII’s supply of doses via COVAX is expected to increase substantially into Quarter 1 2022,” it added.
